STATE OF NEW YORK
________________________________________________________________________
8339--A
Cal. No. 391
2021-2022 Regular Sessions
IN ASSEMBLY
October 20, 2021
___________
Introduced by M. of A. GONZALEZ-ROJAS, SIMON, GRIFFIN, ENGLEBRIGHT,
SEAWRIGHT, DICKENS, GOTTFRIED, ABINANTI, KELLES, JACOBSON, McDONALD,
DINOWITZ, ANDERSON, CAHILL, STIRPE, GALEF -- Multi-Sponsored by -- M.
of A. COOK -- read once and referred to the Committee on Health --
recommitted to the Committee on Health in accordance with Assembly
Rule 3, sec. 2 -- advanced to a third reading, passed by Assembly and
delivered to the Senate, recalled from the Senate, vote reconsidered,
bill amended, ordered reprinted, retaining its place on the order of
third reading
AN ACT to amend the tax law, in relation to requiring the department of
health to publish certain reports on department's website detailing
sales of opioids sold in the state
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Short title. This act shall be known and may be cited as
2 the "registered opioid sales for transparency and epidemic recovery
3 (ROSTER) act".
4 § 2. Subdivision (g) of section 498 of the tax law, as added by
5 section 1 of part XX of chapter 59 of the laws of 2019, is amended to
6 read as follows:
7 (g) Each registrant shall provide a report to the department of health
8 detailing all opioids sold by such registrant in the state of New York.
9 Such report shall include:
10 (i) the registrant's name, address, phone number, federal Drug
11 Enforcement Agency (DEA) registration number, education department
12 registration number, and controlled substance license number issued by
13 the department of health, if applicable;
14 (ii) the name, address and DEA registration number of the entity to
15 whom the opioid was sold;
16 (iii) the date of the sale of the opioid;
17 (iv) the gross receipt total, in dollars, for each opioid sold;
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD13199-03-2
A. 8339--A 2
1 (v) the name and National Drug Code of the opioid sold;
2 (vi) the number of containers and the strength and metric quantity of
3 controlled substance in each container of the opioid sold;
4 (vii) the total number of morphine milligram equivalents sold; and
5 (viii) any other elements as deemed necessary by the commissioner of
6 health.
7 Such information shall be reported and published annually in such form
8 as defined by the commissioner of health and shall not be subject to the
9 provisions of section four hundred ninety-nine of this article, with the
10 exception of paragraph (ii) of this subdivision. The information
11 collected in such report shall be made available to the public in
12 machine-readable formats and such report shall be made publicly avail-
13 able on the department of health's website.
14 § 3. Within ninety days of the effective date of this act, the depart-
15 ment of health shall compile and publish on its website all reports
16 submitted to the department detailing all opioids sold by a registrant
17 in the state of New York pursuant to subdivision (g) of section 498 of
18 the tax law, including the initial report with transaction information
19 from July 1, 2019 through December 31, 2019 and each annual report ther-
20 eafter.
21 § 4. This act shall take effect immediately.
